Immune cellular components and signaling pathways in the tumor microenvironment is a research paper published in Seminars in Cancer Biology (2022). On theSindex it has a DataRank of 1.5. It has been cited 52 times, with 51 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0.889
From 35 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 51 citers.
National Institutes of Health
Grant: R01CA212605
National Institutes of Health
Grant: R01CA229784
National Institutes of Health
Grant: R01CA238263
Juvenile Diabetes Research Foundation United States of America
Grant: 1-INO-2002-1119-A-N
Juvenile Diabetes Research Foundation United States of America
Grant: SRA 2020-0033
National Institutes of Health
Grant: 1R01CA212605-01A1
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
National Institutes of Health
Grant: 5R01CA238263-03
The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
National Institutes of Health
Grant: 5R01CA229784-04
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
AstraZeneca
Bristol-Myers Squibb
Novartis
Roche
Boehringer Ingelheim
Merck
FWCI
3.09
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals